Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]

New Targets Identified For Lupus and Rheumatoid Arthritis

Researchers part of a public-private partnership have identified new targets for the treatment of autoimmune diseases, including lupus and rheumatoid arthritis. That’s according to...

Bayer, Foundation Medicine to Develop NGS-Based Pan-Cancer CDx

Bayer AG and Foundation Medicine announced a global collaboration for the development and commercialization of NGS-based companion diagnostics, that will cut across multiple oncology...
Source: xrender/Getty Images

Protein Misfolding a Potential Cause, Not Result, of Metabolic Disorders

MUSC research discover a novel mechanism that triggers unfolded protein response in cells and may trigger a range of metabolic disorders
Source: vchal/Getty Images

CRISPR Gene Editing Can Introduce Hundreds of Unintended Mutations

Columbia University findings present cautionary tale amidst accelerating use of CRISPR-Cas9 for research and therapeutic development.
Source: iStock/ktsimage

DNA Repair Map Created for Entire Human Genome

Scientists at the University of North Carolina School of Medicine and UNC Lineberger Comprehensive Cancer Center say they have developed a technique for finding...

Qiagen’s therascreen PIK3CA Kit Approved as CDx for Novartis’ Breast Cancer Drug Piqray

Qiagen is launching its therascreen® PIK3CA RGQ PCR Kit (therascreen PIK3CA Kit) as a companion diagnostic to help identify breast cancer patients eligible for...
Source: wildpixel/Getty Images

Gut Bacteria Link Dietary Fiber with Liver Cancer

Mice developed HCC when fed diets fortified with refined soluble fibers, casting doubts over the practice of adding them to processed foods
Source: steele/Getty Images

Colitis Reduced by Gut Microbiome-Pomegranate Partnership

Researchers in India and U.S. demonstrate how a pomegranate-derived metabolite can help protect against and reduce symptoms of IBD

Mount Sinai Launches Collaboration with Regeneron Genetics Center

The collaboration looks to perform whole exome sequencing on 33,000 DNA and plasma samples housed in Mount Sinai's BioMe biobank.

Protagen Licenses BICD2 to Inova Dx

The license agreement will enable Inova to add the biomarker to its portfolio of connective tissue disease reagents.
Scroll Up